NEWS FROM THE AMERICAN COLLEGE OF SURGEONS | FOR IMMEDIATE RELEASE
CHICAGO (December 5, 2016): Nationally recognized oncologist Lawrence N. Shulman, MD, FACP, has begun a two-year term as Chair of the Commission on Cancer (CoC) of the American College of Surgeons (ACS). Dr. Shulman’s election as chair was announced during the CoC Annual Meeting on Oct. 16 in Washington, DC. The meeting was held during the ACS Clinical Congress, one of the largest international meetings of surgeons in the world.
Dr. Shulman is the deputy director for clinical services of the Abramson Cancer Center at the University of Pennsylvania, Philadelphia, and director of their newly-formed Center for Global Cancer Medicine. He specializes in treating breast cancer patients, and his research includes development of new cancer therapies and implementation of cancer treatment programs in low-resource settings.
In his role as Chair of the CoC, Dr. Shulman will serve as a spokesperson for oncology issues addressed by the organization. “I plan to identify priorities for the CoC and the National Cancer Database, and to enhance the relationship between the CoC and its accredited hospital programs. I also hope to explore areas where cancer care and outcomes vary at the national level and determine where and how to drive change to improve those outcomes,” he said. Dr. Shulman also wants to ensure that the CoC is viewed as the organization that plays a major role in driving cancer care quality in the United States. He will serve as an ex-officio member of all the CoC’s subcommittees and work groups, and as a liaison to the ACS Program Committee.
In Dr. Shulman’s positions at the University of Pennsylvania, he has a leadership role in the strategic development of cancer services for the Abramson Cancer Center and its affiliated hospitals. He also leads the Cancer Quality program for the university’s health system and its five hospitals. Prior to Dr. Shulman’s appointment as CoC chair, he served as the Chair of the CoC’s Quality Integration Committee. He is also the former chair of the American Society of Clinical Oncology’s Quality of Care Committee, and has been nominated to serve on the National Cancer Policy Forum of the National Academy. He will assume that role in 2017.
# # #
About the American College of Surgeons
The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and improve the quality of care for all surgical patients. The College is dedicated to the ethical and competent practice of surgery. Its achievements have significantly influenced the course of scientific surgery in America and have established it as an important advocate for all surgical patients. The College has more than 80,000 members and is the largest organization of surgeons in the world. For more information, visit www.facs.org.
About the American College of Surgeons Commission on Cancer
Established in 1922 by the ACS, the CoC is a consortium of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education and the monitoring of comprehensive quality care.
The CoC’s accreditation program encourages hospitals, treatment centers and other facilities to improve their quality of patient care through various cancer-related services. There are currently more than 1,500 CoC-accredited cancer programs in the U.S. and Puerto Rico, representing 30 percent of all hospitals. CoC-accredited facilities diagnose and/or treat more than 70 percent of all newly diagnosed cancer patients each year. For more information on the CoC, visit: https://www.facs.org/quality-programs/cancer/coc.
About Lawrence Shulman, MD, FACP
Dr. Shulman received his bachelor’s degree in organic chemistry from Syracuse University in 1971 and his medical degree from Harvard Medical School in 1975. He completed residency training at Beth Israel Deaconess Hospital, Boston, where he trained in hematology and oncology. In addition to his positions at the University of Pennsylvania, Dr. Shulman serves as senior oncology advisor to the non-profit organization Partners In Health (PIH), where he has helped establish cancer treatment programs in Rwanda and Haiti.